Archive | Robert Ring of Autism Speaks | #AutisticHistory #StopBigAutism #BanABA

Rob Ring of Autism Speaks

[Note: Shared for #AutisticHistory archive purposes. This is NOT An Autistic Ally.]

Robert H. Ring, Vice President of Translational Research

Rob joined Autism Speaks in June of 2011 as Vice President of Translational Research. In this newly created position, Rob is responsible for overseeing the organization’s expanding translational research portfolio, which is focused on moving biological science “from bench to bedside” – or from laboratory experiments into clinical trials – with the goal of improving outcomes for individuals with autism spectrum disorders (ASD).

Organizationally, Rob leads the Division of Translational Neuroscience. He is responsible for overseeing Autism Speaks’ neuroscience-focused grant portfolio, the Post-doctoral fellowship program in Translational Research, and the Autism Tissue Program (ATP) and is spearheading our Translational Medicine Research Initiative.

Prior to joining Autism Speaks, Rob held the position of Senior Director and Head of the Autism Research Unit at Pfizer Worldwide Research and Development in Groton, Connecticut. There he led the first dedicated research group in the pharmaceutical industry focused specifically on the discovery and development of medicines that address unmet clinical needs of individuals living with Autism Spectrum Disorders. Under his leadership, the Autism Research Unit established an innovative research program and diverse portfolio of therapeutic approaches to autism. Working closely with academic centers, governmental agencies, and non-profit foundations around the world, Rob’s multidisciplinary team built an extensive external network of collaborators focused on translating the rapidly advancing science of autism into clinical benefits for the autism population.

Rob is a native of Southern California, where he attended Westmont College (Santa Barbara) and earned a B.A. degree in both Fine Art and Biology. After a brief art career as a painter, he returned to his passion for science, earning a Ph.D. in Molecular Neurobiology from the City of Hope National Medical Center (Duarte, California) before moving into the Pharmaceutical Industry. With over a decade of experience as a neuroscientist working in psychiatric drug discovery and development, Rob has an extensive background in translational research. He is a recognized expert in neuropeptide systems of the central nervous system, with a particular research interest in oxytocin and vasopressin.

Rob holds adjunct faculty appointments in Psychiatry at Mount Sinai School of Medicine (New York) and Pharmacology and Physiology at Drexel University College of Medicine (Philadelphia). He is also a member in numerous professional societies including the International Society for Autism Research, American College of Neuropsychopharmacology, Society for Biological Psychiatry, and Society for Neurosciences.

Rob resides in Southeastern Connecticut with his wife and two children.

via autism speaks



Autistic people have fought the inclusion of ABA in therapy for us since before Autism Speaks, and other non-Autistic-led autism organizations, started lobbying legislation to get it covered by insurances and Medicaid. 

ABA is a myth originally sold to parents that it would keep their Autistic child out of an institution. Today, parents are told that with early intervention therapy their child will either be less Autistic or no longer Autistic by elementary school, and can be mainstreamed in typical education classes. ABA is very expensive to pay out of pocket. Essentially, Autism Speaks has justified the big price tag up front will offset the overall burden on resources for an Autistic’s lifetime. The recommendation for this therapy is 40 hours a week for children and toddlers.

The original study that showed the success rate of ABA to be at 50% has never been replicated. In fact, the study of ABA by United States Department of Defense was denounced as a failure. Not just once, but multiple times. Simply stated: ABA doesn’t workIn study after repeated study: ABA (conversion therapy) doesn’t work. 

What more recent studies do show: Autistics who experienced ABA therapy are at high risk to develop PTSD and other lifelong trauma-related conditions. Historically, the autism organizations promoting ABA as a cure or solution have silenced Autistic advocates’ opposition. ABA is also known as gay conversion therapy.

The ‘cure’ for Autistics not born yet is the prevention of birth. 

The ‘cure’ is a choice to terminate a pregnancy based on ‘autism risk.’ The cure is abortion. This is the same ‘cure’ society has for Down Syndrome. 

This is eugenics 2021. Instead of killing Autistics and disabled children in gas chambers or ‘mercy killings’ like in Aktion T4, it’ll happen at the doctor’s office, quietly, one Autistic baby at a time. Different approaches yes, but still eugenics and the extinction of an entire minority group of people.

Fact: You can’t cure Autistics from being Autistic.

Fact: You can’t recover an Autistic from being Autistic.

Fact: You can groom an Autistic to mask and hide their traits. Somewhat. … however, this comes at the expense of the Autistic child, promotes Autistic Burnout (this should not be confused with typical burnout, Autistic Burnout can kill Autistics), and places the Autistic child at high risk for PTSD and other lifelong trauma-related conditions.

[Note: Autism is NOT a disease, but a neurodevelopmental difference and disability.]

Fact: Vaccines Do Not Cause Autism.

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

This site uses Akismet to reduce spam. Learn how your comment data is processed.

%d bloggers like this: